News
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jul 9, 2020Company Completes Critical Milestone in Development of "Universal Donor" Stem Cell Therapy for Stroke
(OTC-CELZ) Creative Medical Technology Holdings announced today completion of preclinical studies assessing the anti-inflammatory and neuroregenerative activities of AmnioStem™. These studies...
-
Apr 20, 2020Broad Claims Cover Entire Class of Adult Stem Cells for Treatment of Ovarian Failure
Creative Medical Technology Holdings Inc. (OTC-CELZ) announced today receipt of a Quayle Action on its patent application #15/652213 entitled Methods for Treatment of Premature Ovarian Failure and...
-
Mar 11, 2020Clinical Stage Adult Stem Cell Therapy Company Discovers New Way to Stop Immune Diseases without Immune Suppression
Creative Medical Technology Holdings announced today, what appears to be, the first personalized adoptive immunotherapy for treatment of autoimmunity, which the Company named "IMMCELZ™"....
-
Feb 13, 2020
Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on Urology, Orthopedics and Neurology using adult stem cell treatments, today...
-
Jan 15, 2020
Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, today announced...